These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 335607)

  • 1. Cinoxacin: new antimicrobial agent for urinary tract infections.
    Landes RR; Hall JW
    Urology; 1977 Oct; 10(4):312-6. PubMed ID: 335607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of feline urinary tract pathogens and antimicrobial resistance over five years.
    Teichmann-Knorrn S; Reese S; Wolf G; Hartmann K; Dorsch R
    Vet Rec; 2018 Jul; 183(1):21. PubMed ID: 29622684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cinoxacin and trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
    Schaeffer AJ; Flynn S; Jones J
    J Urol; 1981 Jun; 125(6):825-7. PubMed ID: 7241682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
    Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
    Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
    Swarifi R; Lee M; Ojeda L; Tabib M
    J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic guidelines in the management of urinary tract infections and pyelonephritis.
    Turck M
    Urol Clin North Am; 1975 Oct; 2(3):443-50. PubMed ID: 1103409
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of outpatient urinary tract infections with cinoxacin.
    Jones GW; Mulholland SG
    J Fam Pract; 1980 Aug; 11(2):207-10. PubMed ID: 6997428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark.
    Córdoba G; Holm A; Hansen F; Hammerum AM; Bjerrum L
    BMC Infect Dis; 2017 Oct; 17(1):670. PubMed ID: 29017466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections.
    Boerema JB; Pauwels R; Scheepers J; Crombach W
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():103-9. PubMed ID: 3519564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Our experience in the microbiological diagnosis and treatment of chronic urinary tract infections].
    Sónak R; Antolová T; Dunová A; Komadelová A; Zvara V; Stojkovic J
    Rozhl Chir; 1974 Jun; 53(6):388-93. PubMed ID: 4603194
    [No Abstract]   [Full Text] [Related]  

  • 11. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B; Gebre-Selassie S; Feleke Y
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feline urinary tract pathogens: prevalence of bacterial species and antimicrobial resistance over a 10-year period.
    Dorsch R; von Vopelius-Feldt C; Wolf G; Straubinger RK; Hartmann K
    Vet Rec; 2015 Feb; 176(8):201. PubMed ID: 25351232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Escherichia coli isolated from bitches with pyometra and from urine samples from other dogs.
    Hagman R; Greko C
    Vet Rec; 2005 Aug; 157(7):193-6. PubMed ID: 16100369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections.
    Ceran N; Mert D; Kocdogan FY; Erdem I; Adalati R; Ozyurek S; Goktas P
    J Infect Chemother; 2010 Dec; 16(6):424-30. PubMed ID: 20585969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Accuracy of antibiograms performed directly from urine incubation bottles of the Sebac system for diagnosing bacteriuria].
    Sevin E; Deschamps C; Legrand P
    Ann Biol Clin (Paris); 2000; 58(3):372-5. PubMed ID: 10846244
    [No Abstract]   [Full Text] [Related]  

  • 16. Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
    Cox CE; Simmons JR
    South Med J; 1982 May; 75(5):549-50. PubMed ID: 7043747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinoxacin in therapy of urinary tract infections. Comparison of two dosage regimens.
    Cox CE; Simmons JR
    Urology; 1981 Jun; 17(6):539-41. PubMed ID: 7018051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infections.
    Casellas JM; Tome G; Exeni R; Grimoldi I; Goldberg M; Farinati AE
    Pathol Biol (Paris); 1993 Apr; 41(4):385-91. PubMed ID: 8233640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections.
    Boyer JL; Andriole VT
    Yale J Biol Med; 1968 Feb; 40(4):284-95. PubMed ID: 4870320
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.